Berenberg Bank reiterates €82.20 price target for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) was assigned a price target of €82.20 ($87.45) by stock analysts at Berenberg Bank in a research report released Tuesday to clients and investors, Borsen Zeitung reports. Berenberg Bank’s price target indicates upside potential of 46.58% from the stock’s previous close.

FME has been the subject of several other reports. Barclays set a price target of €68.00 ($72.34) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, April 26 report. Jefferies Financial Group set a price target of €53.00 ($56.38) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, February 22 report. Warburg Research set a €62.00 ($65.96) price target on Fresenius Medical Care AG & Co. KGaA in a Tuesday, May 10 research note. Deutsche Bank Aktiengesellschaft set a price target of €58.00 ($61.70) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 research note. Finally, UBS Group set a price target of €75.00 ($79.79) on Fresenius Medical Care AG & Co. KGaA in a Wednesday, May 11 report.

FME Share traded down €0.22 ($0.23) in Tuesday’s trading, reaching €56.08 ($59.66). The company had a trading volume of 385,545 shares, compared to an average volume of 704,197. The company has a quick ratio of 0.76, a current ratio of 1.10 and a leverage ratio of 95.29. The company has a 50-day moving average price of €59.98 and a 200-day moving average price of €58.26. Fresenius Medical Care AG & Co. KGaA has a 1-year minimum of €50.98 ($54.23) and a 1-year maximum of €71.14 ($75.68). The company has a market capitalization of $16.43 billion and a PE ratio of 16.95.

Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Read more



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.